Pfizer (PFE) Intangibles (2009 - 2026)
Pfizer's Intangibles was $47.05 billion in Q2 2026, down 10.7% from $52.7 billion a year earlier and down 10.5% from the prior quarter.
Powered by 
Analysis
Pfizer (PFE) Intangibles (2009 - 2026) Analysis & Trends
At the end of FY2025, Intangibles at Pfizer came in at $53.73 billion, down 3.0% from FY2024.
- Intangibles shows a five-year compound annual growth rate of 13.7% (FY2020 to FY2025).
- In earlier years, Intangibles was $55.41 billion in FY2024 (-14.6%), $64.9 billion in FY2023 (+49.6%), $43.37 billion in FY2022 (+72.5%) and $25.15 billion in FY2021 (-11.3%).
- The Q2 2026 figure marks the lowest quarterly Intangibles since Q2 2023.
- Compared with a year earlier, Intangibles has declined for seven straight quarters, with an average decline of 10.5% over the last seven quarters.
- The best year-over-year quarter for Intangibles over five years was Q4 2022 (growth of 72.5%); the worst was Q3 2021 (a decline of 14.9%).
- Per Business Quant data, PFE's Intangibles in the three quarters before Q2 2026 was $52.56 billion (Q1 2026), $53.73 billion (Q4 2025) and $51.32 billion (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Intangibles (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,082.65 Bn | 1,051.23 Bn | 19.71 Bn | 18.11 Bn |
| 2 | Johnson & Johnson | 623.68 Bn | 542.21 Bn | 17.26 Bn | 48.23 Bn |
| 3 | AbbVie | 459.43 Bn | 432.59 Bn | 12.70 Bn | 49.14 Bn |
| 4 | Merck | 354.80 Bn | 309.23 Bn | 12.21 Bn | 24.98 Bn |
| 5 | Novartis Ag | 269.16 Bn | 225.03 Bn | 11.24 Bn | 42.07 Bn |
| 6 | Astrazeneca | 244.40 Bn | 217.97 Bn | 12.86 Bn | 37.72 Bn |
| 7 | Amgen | 220.17 Bn | 175.57 Bn | 7.24 Bn | 20.49 Bn |
| 8 | Gilead Sciences | 183.05 Bn | 157.16 Bn | 6.22 Bn | 14.03 Bn |
| 9 | Pfizer | 160.27 Bn | 107.22 Bn | 10.94 Bn | 47.05 Bn |
| 10 | Vertex Pharmaceuticals | 128.38 Bn | 100.39 Bn | 2.84 Bn | 412.80 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 28, 2026 | 47.05 Bn |
| Mar 29, 2026 | 52.56 Bn |
| Dec 31, 2025 | 53.73 Bn |
| Sep 28, 2025 | 51.32 Bn |
| Jun 29, 2025 | 52.70 Bn |
| Mar 30, 2025 | 53.98 Bn |
| Dec 31, 2024 | 55.41 Bn |
| Sep 29, 2024 | 59.99 Bn |
| Jun 30, 2024 | 61.24 Bn |
| Mar 31, 2024 | 62.83 Bn |
| Dec 31, 2023 | 64.90 Bn |
| Jul 2, 2023 | 41.41 Bn |
| Apr 2, 2023 | 42.00 Bn |
| Dec 31, 2022 | 43.37 Bn |
| Jul 3, 2022 | 29.07 Bn |
| Apr 3, 2022 | 29.82 Bn |
| Dec 31, 2021 | 25.15 Bn |
| Oct 3, 2021 | 26.31 Bn |
| Jul 4, 2021 | 27.32 Bn |
| Apr 4, 2021 | 27.97 Bn |
API Access
Pfizer Intangibles API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=intangibles&ticker=PFE&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "intangibles", "ticker": "PFE", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=intangibles&ticker=PFE&period=max&api_key=YOUR_API_KEY");
const data = await res.json();